RichFakir rates Sahajanand Medical Technologies Ltd's business quality as poor — 36/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation).
On our model, Sahajanand Medical Technologies Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Sahajanand Medical Technologies Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Sahajanand Medical Technologies Ltd's fair value is about ₹5 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →